Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Rebecca Zisser/Axios

Some scientists are calling on the Food and Drug Administration to establish standards for advanced algorithms that are developing at a "staggering" pace before they are put in medical devices to help predict patients' outcomes.

What's new: Advanced algorithms are starting to be deployed in some devices to help provide automated real-time predictions, but these offer a whole new level of possibilities and challenges from older predictive tools. Standards are needed to check for safety and effectiveness before they are implemented in a clinical setting, the scientists say in a policy forum in Science Thursday.

The FDA tells Axios it is working on developing a framework to handle advances in AI and medicine, as pointed out by Commissioner Scott Gottlieb last year. While unable to comment on this paper, a spokesperson says the FDA has used its current process for novel medical devices to authorize these AI algorithms:

  • Viz.ai for helping providers detect stroke in CT scans.
  • IDx-DR for detecting diabetic retinopathy.
  • OsteoDetect for detecting bone fractures.

Meanwhile, Ravi B. Parikh, co-author of the paper and a fellow at University of Pennsylvania's School of Medicine, tells Axios that the FDA needs to set standards to evaluate the "staggering" pace of AI development. He adds:

"Five years ago, AI and predictive analytics had yet to make a meaningful impact in clinical practice. In just the past 2-3 years, premarket clearances have been granted for AI applications ranging from sepsis prediction to radiology interpretation."
"But if these tools are going to be used to determine patient care ... they should meet standards of clinical benefit just as the majority of our drugs and diagnostic tests do. We think being proactive in creating and formalizing these standards is essential to protecting patients and safely translating algorithms to clinical interventions."

Why it matters: Advanced algorithms present both opportunities and challenges, says Amol S. Navathe, co-author and assistant professor at Penn's School of Medicine. He tells Axios:

"The real opportunity is that these algorithms outperform clinicians in medical decisions, not a small feat. The challenge is that the data generated for algorithms is not randomly generated, rather, most of [what] the data algorithms 'see' is a result of a human decision. We have a ways to go in our scientific approaches to overcome this challenge and uniformly develop algorithms that can help improve upon human clinician decisions."

Details: The authors list the following as recommended standards...

  1. Meaningful endpoints for clinical benefit from the algorithms should be rigorously validated by the FDA, such as downstream outcomes like overall survival or clinically relevant metrics like the number of misdiagnoses.
  2. Appropriate benchmarks should be determined, similar to the recent example of the FDA approving Viz.AI, the deep-learning algorithm for diagnosing strokes, after it was able to diagnose strokes on computed tomography imaging more rapidly than neuroradiologists.
  3. Variable input specifications should be clarified for all institutions, such as defining inputs for electronic health records so results are reliable across institutions. Plus, algorithms should be trained on data sources from as broadly representative populations as possible so they are generalizable across all populations.
  4. Guidance on possible interventions that would be connected to an algorithm's findings to improve patient care should be considered.
  5. Run rigorous audits after FDA clearance or approval, particularly to check on how the new variables included by deep-learning may have altered its performance over time. For instance, regular audits could find the algorithm had a systematic bias against certain groups after being deployed across large populations. This could be tracked in a manner similar to the current FDA Sentinel Initiative program for approved drugs and devices.

Outside comment: Eric Topol, founder and director of Scripps Research Translational Institute, who was not part of this paper, says the timing of these proposed standards is "very smart" before advanced algorithms are placed into too many devices.

  • "[The algorithm] doesn't translate necessarily into helping people," Topol tells Axios. "It can actually have no benefit."
  • Even worse, he adds, if the variables are off, the predictive analyses can have negative ramifications.

What's next: The scientists hope the FDA considers integrating the proposed standards alongside its current pre-certification program under the Digital Health Innovation Act to study clinical outcomes of AI-based tools, Ravi says.

Go deeper

Nathan Bomey, author of Closer
1 hour ago - Economy & Business

Tesla delays Cybertruck until 2023

Tesla debuts the Cybertruck in Hawthorne, Calif., on Nov. 21, 2019. Photo: Frederic J. Brown/AFP via Getty Images

Tesla is at risk of falling behind on one of the most critical products in the American auto industry: pickups.

Why it matters: Pickups are the most profitable segment in the business and account for the first, second and third best-selling vehicles in the country. Without a serious pickup strategy, Tesla could miss out on a huge source of future income.

Defense taking steps to mitigate civilian harm after botched airstrikes

Secretary of Defense Lloyd Austin speaks during a news conference at the Pentagon in Arlington, Virginia on Sept. 1, 2021. Photo: Andrew Harrer/Bloomberg via Getty Images

Defense Secretary Lloyd Austin issued a directive Thursday to improve the U.S. military's approach to civilian harm mitigation and response, calling it a "strategic and a moral imperative."

Why it matters: The Pentagon has faced criticism for years for amassing civilian casualties in its missions, especially in the Middle East. New York Times investigations have found systemic failures in efforts to prevent civilian deaths, as well as a cover-up of a 2019 airstrike that killed dozens of women and children in Syria.

4 hours ago - World

Mapped: The world's most and least corrupt countries

Expand chart
Data: Transparency International; Map: Jared Whalen/Axios

The most corrupt governments in the world are in South Sudan, Syria and Somalia, according to Transparency International's annual index, while the "cleanest" are in Denmark, Finland and New Zealand.

  • Breaking it down: The U.S. is 27th, China 66th, India 85th, Brazil 96th and Russia 136th. Scroll over the map to see each country's ranking.